Daihan Pharmaceutical Co.,Ltd. (KOSDAQ:023910)

Daihan Pharmaceutical Revenue

Daihan Pharmaceutical had revenue of 54.85B KRW in the quarter ending September 30, 2024, with 7.70% growth. This brings the company's revenue in the last twelve months to 201.97B, up 3.83% year-over-year. In the year 2023, Daihan Pharmaceutical had annual revenue of 195.91B with 6.32% growth.

• Revenue (ttm): 201.97B
• Revenue Growth: +3.83%
• P/S Ratio: 0.76
• Revenue / Employee: 365.23M
• Employees: 553
• Market Cap: 152.88B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	195.91B	11.64B	6.32%
Dec 31, 2022	184.27B	12.80B	7.47%
Dec 31, 2021	171.46B	5.38B	3.24%
Dec 31, 2020	166.08B	-2.68B	-1.59%
Dec 31, 2019	168.76B	10.04B	6.33%